Literature DB >> 18383466

Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.

Klemens Högenauer1, Andreas Billich, Charles Pally, Markus Streiff, Trixie Wagner, Karl Welzenbach, Peter Nussbaumer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383466     DOI: 10.1002/cmdc.200800037

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  6 in total

Review 1.  Sphingosine kinase regulation and cardioprotection.

Authors:  Joel S Karliner
Journal:  Cardiovasc Res       Date:  2008-11-18       Impact factor: 10.787

2.  Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.

Authors:  Rebeca Geffin; Ricardo Martinez; Alicia de Las Pozas; Biju Issac; Micheline McCarthy
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

Review 3.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

Review 4.  Role of Sphingosine Kinase in Type 2 Diabetes Mellitus.

Authors:  Yanfei Qi; Wei Wang; Ziyu Song; Gulibositan Aji; Xin Tracy Liu; Pu Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-09       Impact factor: 5.555

5.  FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.

Authors:  Nobumasa Takasugi; Tomoki Sasaki; Ihori Ebinuma; Satoko Osawa; Hayato Isshiki; Koji Takeo; Taisuke Tomita; Takeshi Iwatsubo
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

Review 6.  The emerging role of FTY720 (Fingolimod) in cancer treatment.

Authors:  Christopher White; Heba Alshaker; Colin Cooper; Matthias Winkler; Dmitri Pchejetski
Journal:  Oncotarget       Date:  2016-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.